Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway | Cancer Cell International | Full Text
The therapeutic potential of targeting tryptophan catabolism in cancer | British Journal of Cancer
Molecules | Free Full-Text | Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening
TDO2 modulates liver cancer cell migration and invasion via the Wnt5a pathway
Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities: Trends in Pharmacological Sciences
Anti-TDO2 Antibody (CAB13182) | WB
Type I interferon signaling induces Tdo2 and the tryptophan-kynurenine... | Download Scientific Diagram
STS inhibited the enzymatic activity of IDO1 and TDO2... | Download Scientific Diagram
A comprehensive analysis of TDO2 expression in immune cells and characterization of immune cell phenotype in TDO2 knockout mice | SpringerLink
Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer: Molecular Therapy - Oncolytics